Capricor Therapeutics (CAPR) Amortization of Deferred Charges (2013 - 2014)
Capricor Therapeutics (CAPR) recorded quarterly Amortization of Deferred Charges of -$1.0 million in Q4 2014, little changed quarter-over-quarter from -$1.0 million in Q3 2014.
Capricor Therapeutics (CAPR) Amortization of Deferred Charges (2013 - 2014) Analysis & Trends
Capricor Therapeutics' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$1.0 million for Q4 2014.
- In Q4 2014, Amortization of Deferred Charges changed N/A year-over-year to -$1.0 million; the TTM figure through Dec 2014 stood at $8.3 million (changed N/A YoY), while the FY2014 annual figure was $8.3 million, changed N/A from the prior year.
- Amortization of Deferred Charges was -$1.0 million for Q4 2014 at Capricor Therapeutics, roughly flat from -$1.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $11.5 million in Q1 2014 to a low of -$1.0 million in Q2 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.04 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Sep 30, 2014 | -1.04 Mn |
| Sep 30, 2014 | -1.04 Mn |
| Jun 30, 2014 | -1.04 Mn |
| Jun 30, 2014 | -1.04 Mn |
| Mar 31, 2014 | 11.46 Mn |
| Mar 31, 2014 | 11.46 Mn |
| Jun 30, 2013 | -3,711.00 |
| Jun 30, 2013 | -3,711.00 |
| Mar 31, 2013 | 3,711.00 |
| Mar 31, 2013 | 3,711.00 |